Mia's Feed
Medical News & Research

New Insights into Glioblastoma: Cell Clustering May Influence Tumor Aggressiveness

New Insights into Glioblastoma: Cell Clustering May Influence Tumor Aggressiveness

Share this article

New research uncovers how glioblastoma cell clustering influences tumor severity. Dispersed cells show higher plasticity and treatment resistance, offering potential new therapeutic targets.

2 min read

Recent research from the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has uncovered new details about glioblastoma, one of the most aggressive brain tumors. Using advanced spatial transcriptomics technology, scientists observed that glioblastoma cells tend to form clusters of the same cell type and that these clustered cells are less aggressive compared to dispersed cells that break away from these groups. Interestingly, the dispersed tumor cells exhibit higher plasticity, meaning they can easily change their properties, which is associated with increased treatment resistance and poorer patient outcomes.

The study revealed that tumor cells in clusters express surface proteins that help them stick together, while dispersed cells lack these adhesion molecules, making them more mobile and adaptable. These findings were also confirmed in breast cancer samples, suggesting that the principles governing tumor cell behavior might be applicable across various solid cancers.

The researchers hypothesize that current treatments like chemotherapy and radiation might inadvertently cause tumor cells to disperse by disrupting their clusters, thereby increasing their plasticity and harmfulness. Understanding the mechanisms behind cell clustering and dispersal could open new pathways for therapy, aiming to promote cluster formation or inhibit cell dispersal to reduce tumor aggressiveness.

Led by Dr. Anna Lasorella and Dr. Antonio Iavarone, the team’s work provides a deeper understanding of the biology of glioblastoma and offers hope for developing strategies to limit tumor progression by controlling cell adhesion and plasticity. Their findings emphasize the potential of targeting tumor cell organization to improve treatment outcomes for patients with this deadly cancer.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Promising Results from DeLLphi-303: Safety and Survival in Extensive-Stage Small Cell Lung Cancer

Clinical trial results reveal an acceptable safety profile and unprecedented survival rates in patients with extensive-stage small cell lung cancer treated with tarlatamab combined with anti-PD-L1 therapy, marking a significant advance in lung cancer research.

Rising Uninsured Rates to Challenge Local Healthcare Systems

An anticipated rise in uninsured Americans is expected to strain healthcare systems nationwide, particularly impacting rural communities and vulnerable populations. Learn about the challenges and policy implications.

Enhanced Diabetes Research with Vascularized Stem Cell Islet Organoids

Scientists have developed vascularized stem cell-derived pancreatic organoids that better mimic the natural environment of the pancreas, enhancing diabetes research and therapy development.

Innovative Organoid Platform Enhances Precision in Antibody and Vaccine Effectiveness Testing

A novel respiratory organoid platform developed by HKU enhances the accuracy of evaluating antibody and vaccine effectiveness against COVID-19, aligning lab results with real-world outcomes and promising to accelerate drug development.